Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Direct visualization of membrane architecture of myelinating cells in transgenic mice expressing membrane-anchored EGFP.
Immune-mediated inflammatory diseases: progress in molecular pathogenesis and therapeutic strategies.
Frequency analysis approach to study balance control in individuals with multiple sclerosis.
Epigenetics and the Modulation of Neuroinflammation.
A case of tumor-like inflammatory demyelinating disease with progressive brain and spinal cord involvement.
RORγt Expression and Lymphoid Neogenesis in the Brain of Patients with Secondary Progressive Multiple Sclerosis.
Multiple sclerosis: Scoring system to predict response to IFN-β in patients with multiple sclerosis.
Identification of Inflammatory Neuronal Injury and Prevention of Neuronal Damage in Multiple Sclerosis: Hope for Novel Therapies?
Analysis of tremor in multiple sclerosis using Hilbert-Huang Transform.
Dietary Sutherlandia and Elderberry Mitigate Cerebral Ischemia-Induced Neuronal Damage and Attenuate p47phox and Phospho-ERK1/2 Expression in Microglial Cells.
Microparticles: A New Perspective in Central Nervous System Disorders.
Vitamin D-binding Protein in Cerebrospinal Fluid is Associated with Multiple Sclerosis Progression.
Certified occupational therapy assistants.
Myelin damage and repair in pathologic CNS: challenges and prospects.
Can we predict the evolution of an unpredictable disease like multiple sclerosis?
Act1 mediates IL-17-induced EAE pathogenesis selectively in NG2(+) glial cells.
Mesenchymal stem cells differentially modulate effector CD8+ T cell subsets and exacerbate experimental autoimmune encephalomyelitis.
Multiple sclerosis and pregnancy.
What place for {blacktriangledown}cannabis extract in MS?
A new in vitro mouse oligodendrocyte precursor cell migration assay reveals a role for integrin-linked kinase in cell motility.
Inflammation, Iron, Energy Failure, and Oxidative Stress in the Pathogenesis of Multiple Sclerosis.
[There is evidence for the use of cannabinoids for symptomatic treatment of multiple sclerosis.]
Oligoclonal restriction of antiviral immunoreaction in oligoclonal band-negative MS patients.
Lack of Association between Pulse Steroid Therapy and Bone Mineral Density in Patients with Multiple Sclerosis.
CSF neurofilament and N-acetylaspartate related brain changes in clinically isolated syndrome.

Pages